Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Single-Patient Study for the Emergency Use of Natalizumab (Antegran) in the Treatment of Pediatric Multiple Sclerosis
082
Authors/Disclosures
Jaime Toro, MD, FAAN (Universidad El Bosque) Dr. Toro has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Watch Neurology .
No disclosure on file
David F. Cuellar Giraldo, Jr., MD (Universidad El Bosque) Dr. Cuellar Giraldo has nothing to disclose.
Nathan Tagg, MD (Duke Eye Center) Dr. Tagg has stock in Apple, Birkshire Hathaway, Medtronic.
Saul Reyes, MD (The Royal London Hospital) Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BIIB. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen.
No disclosure on file
Luis F. Orozco-Cabal No disclosure on file
No disclosure on file